
Christoph Correll, MD: Professor and Chair, Department of Child and Adolescent Psychiatry at the Charité University Medicine – Berlin, in Berlin, Germany. He also serves as Clinical Professor of Psychiatry and Molecular Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and Professor at the Feinstein Institutes for Medical Science, both in New York, USA.
Professor Correll has authored and co-authored more than 1,200 journal articles that have been cited over 120,000 times, and in September of 2026 his Google Scholar h-index was 170. He has been the Principal Investigator or Steering Committee member of several large, federally funded grants, including national research centers and has served on several expert consensus panels on the use of antipsychotics across a range of psychiatric disorders. He has received more than 40 national and international research awards and fellowships for his work. Since 2014, the year of inception of this metric, Professor Correll has been listed each year by Thomson Reuters/Clarivate/Web of Science as one of “The most influential scientific minds” and “Top 1% cited scientists in the area of psychiatry.”
Professor Correll’s research and clinical work focus on the identification, characterization and psychopharmacological management of adults and youth with severe psychiatric disorders. His areas of expertise include schizophrenia, bipolar disorder, major depression and other psychotic, mood and autism/disruptive behavior spectrum disorders, ranging from the prodrome to first episode, multi-episode and refractory illness patients. His work focuses further on psychopharmacology, epidemiology, clinical high-risk research, clinical trials, comparative effectiveness, meta-analyses, the risk–benefit evaluation of psychotropic medications, and the interface between physical health and mental health.
Institutional Affiliations
Feinstein Institutes for Medical Research
Charité – Universitätsmedizin Berlin
Research Profiles
Neurotorium Contributions
Pharmacological treatment of schizophrenia – Video
Unmet medical needs in Bipolar Disorder – Video
Novel and emerging pharmacologic treatments for Schizophrenia – Article
Novel and emerging pharmacologic treatments for Schizophrenia – Video
Diagnostic challenges in Bipolar Disorder – Video
Schizophrenia and Substance Use Disorders comorbidity – Video